サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ワクチン包装の世界市場：2023年～2030年
市場調査レポート
商品コード
1382543

ワクチン包装の世界市場：2023年～2030年

Global Vaccine Packaging Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 192 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ワクチン包装の世界市場：2023年～2030年
出版日: 2023年11月17日
発行: DataM Intelligence
ページ情報: 英文 192 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界のワクチン包装市場は、2022年に13億米ドルとなり、2023年～2030年の予測期間中にCAGR13.2％で成長し、2030年までに29億米ドルに達すると予測されています。

ワクチン接種は、現代における最も重要な公衆衛生介入のひとつです。天然痘からポリオに至るまで、数多くの致命的な疾病の根絶、制御、蔓延の減少に極めて重要な役割を果たしてきました。しかし、ワクチンの有効性は、その背景にある科学的根拠だけでなく、安全で確実な包装にも左右されます。

ワクチン包装市場は、ヘルスケア、医薬品、包装資材の世界が交差するダイナミックなセクターです。ワクチンの効力を維持するためには特定の温度範囲内で保管する必要があるため、COVID-19パンデミックの際にワクチンにスポットライトが当てられたことから、その重要性は近年ますます高まっています。

一次包装は、市場シェアの1/3以上を占めています。同様に、アジア太平洋地域がワクチン包装市場を独占しており、1/3以上の最大市場シェアを獲得しています。新興経済国へのワクチン接種アクセスの増加と主要企業の存在が、この地域の優位性の主な理由です。

ダイナミクス

コールドチェーンロジスティクスの高度化と持続可能性・環境への配慮

コールドチェーンの維持はワクチンの有効性にとって極めて重要です。ワクチンの腐敗を防ぐためには、特定の温度で保管・輸送する必要があります。こうした事実が、コールドチェーンロジスティクスと先進パッケージングの進歩につながっています。このニーズに応えるため、Sonoco ThermoSafeのような企業は、正確な温度でのワクチンの航空貨物輸送用に設計されたPegasus ULDのような革新的なパッケージングソリューションを発売しました。

しかしながら、持続可能性と環境に優しい包装ソリューションが重視されるようになってきています。政府や組織は、機能性だけでなく環境にも配慮した包装材を求めています。2021年、欧州医薬品庁（EMA）は環境に優しいワクチン包装の重要性を強調しました。企業はリサイクル可能で生分解性のある包装オプションで対応しています。

新興市場におけるワクチンへのアクセスの増加

ワクチンのニーズは先進国だけにとどまりません。人口が増加しヘルスケアのニーズが高まっている新興市場は、ワクチン包装業界の重要な促進要因となっています。政府や団体は、これらの地域でワクチンへのアクセスを改善するために取り組んでおり、堅牢なパッケージングソリューションが必要とされています。

例えば、ビル・アンド・メリンダ・ゲイツ財団は、発展途上国におけるワクチン供給イニシアティブへの資金提供や支援に積極的に関与しています。このようなイニシアチブは、新興経済国がワクチンを利用できるようにするだけでなく、これらの新興経済国にワクチンを輸送するためのワクチン包装の必要性を高めるという重要な役割を果たしています。

世界のワクチン接種の取り組みの拡大

ワクチン包装市場の最も大きな促進要因は、世界のワクチン接種の推進です。COVID-19やその他の病気に対するワクチン接種キャンペーンに伴い、これらの救命製品の有効性を確保するために、効率的で安全かつ確実なワクチン包装の必要性が高まっています。世界各国の政府は、ワクチン接種プログラムに多額の投資を行っています。

例えば米国では、疾病対策予防センター（CDC）が2021年5月までに6億100万回以上のCOVID-19ワクチンが接種されたと報告しています。この統計は、世界中でワクチン接種が増加していることを示すものです。このように、世界のワクチン接種の取り組みは市場の主要な促進要因となっています。

規制遵守のニーズの高まり

ワクチンの包装は、世界的に保健当局による厳しい規制の対象となっています。こうした規制は、ワクチンの安全性と有効性を確保するために設けられています。しかし、この市場で事業を展開する企業にとっては、コンプライアンスが大きな抑制要因となります。規制要件を満たすためには、研究開発および品質管理に多額の投資が必要となります。

前述の課題に対応するため、包装企業は規制基準を満たすソリューションを開発してきました。例えば、Schott AGは2020年にiQプラットフォームを導入し、品質管理への包括的なアプローチを提供することで、ワクチンメーカーが包装プロセス全体を通じてコンプライアンスを維持できるよう支援しています。

一連のコールドチェーン課題

ワクチン包装市場における最も大きな抑制要因の1つは、流通プロセスを通じてコールドチェーンを維持する必要性です。多くのワクチン、特に麻疹、おたふくかぜ、風疹、COVID-19のような病気のワクチンは、効果を維持するために厳密な温度管理が必要です。世界保健機関（WHO）によると、輸送や保管中の温度管理の問題により、世界全体で毎年最大50％のワクチンが廃棄される可能性があります。

このような課題に対し、いくつかのイノベーションが登場しています。例えば2020年、Sonoco ThermoSafeは航空輸送用に設計された温度制御コンテナ、Pegasus ULDを発表しました。この製品は、ワクチンやその他の温度に敏感な医薬品を安全に輸送するための信頼性の高いソリューションを提供することで、コールドチェーンの問題に対処することを目的としています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • コールドチェーンロジスティクスの高度化と持続可能性・環境への配慮
      • 新興市場におけるワクチンへのアクセスの増加
      • 世界のワクチン接種への取り組みの拡大
    • 抑制要因
      • 規制遵守の必要性の高まり
      • 一連のコールドチェーン課題
    • 機会
    • 影響分析

第5章 業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 タイプ別

  • ワクチンクールバッグ
  • バイアルとアンプル
  • 段ボール箱
  • その他

第8章 レベル別

  • 一次
  • 二次
  • 三次

第9章 エンドユーザー別

  • バイオ製薬会社
  • 病院
  • 医療研究所
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Gerresheimer AG
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • West Pharmaceutical Services, Inc
  • Becton, Dickinson & Company
  • SCHOTT AG
  • SGD S.A.
  • Catalent, Inc
  • Stevanato Group
  • Nipro Corporation
  • Piramal Glass Private Limited
  • UDG Healthcare plc

第13章 付録

目次
Product Code: PAC7469

Overview

Global Vaccine Packaging Market reached US$ 1.3 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 13.2% during the forecast period 2023-2030.

Vaccination is one of the most significant public health interventions of the modern era. It has played a pivotal role in eradicating, controlling or reducing the prevalence of numerous deadly diseases, from smallpox to polio. However, the efficacy of vaccines not only depends on the science behind them but also on their safe and secure packaging.

The vaccine packaging market is a dynamic sector that intersects the worlds of healthcare, pharmaceuticals and packaging materials. Its importance has been magnified in recent years, given the spotlight on vaccines during the COVID-19 pandemic as vaccines need to be stored within a specific temperature range to maintain their potency.

The primary packaging, accounts for over 1/3rd of the market share. Similarly, the Asia-Pacific dominates the vaccine packaging market, capturing the largest market share of over 1/3rd. Growing vaccination access to emerging economies and presence of key players are major reason behind the region's dominance.

Dynamics

Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns

Maintaining the cold chain is crucial for vaccine effectiveness. Vaccines must be stored and transported at specific temperatures to prevent spoilage. The respective fact has led to advancements in cold chain logistics and packaging. In response to this need, companies like Sonoco ThermoSafe launched innovative packaging solutions such as Pegasus ULD, designed for air cargo shipments of vaccines at precise temperatures.

Moroever, there is a growing emphasis on sustainability and environmentally friendly packaging solutions. Governments and organizations are seeking packaging materials that are not only functional but also environmentally responsible. In 2021, the European Medicines Agency (EMA) emphasized the importance of eco-friendly vaccine packaging. Companies have responded with recyclable and biodegradable packaging options.

Increasing Access to Vaccines in Emerging Markets

The need for vaccines is not limited to developed countries. Emerging markets, with growing populations and healthcare needs, have become significant drivers in the vaccine packaging industry. Governments and organizations are working to improve access to vaccines in these regions, necessitating robust packaging solutions.

For example, the Bill and Melinda Gates Foundation has been actively involved in funding and supporting vaccine delivery initiatives in developing countries. Such initiatives play crucial role in not only making vaccines available to emerging economies, but also boosts the need for vaccine packaging to transport vaccines in to these emerging economies.

Growing Global Vaccination Efforts

The most significant driver in the vaccine packaging market is the global push for vaccination. With vaccination campaigns against COVID-19 and other diseases, there is a growing need for efficient, safe and secure vaccine packaging to ensure the efficacy of these life-saving products. Governments globally are investing heavily in vaccination programs.

For instance, in U.S., the Centers for Disease Control and Prevention (CDC) reported that more than 601 million COVID-19 vaccine doses had been administered by May 2021. The respective statistics is an indicator of growing vaccination throughout the world. Thus, global vaccination efforts acts major driver for the market.

Growing Need for Regulatory Compliance

Vaccine packaging is subject to stringent regulations imposed by health authorities globally. Such regulations are in place to ensure the safety and efficacy of vaccines. However, compliance can be a significant restraint for companies operating in this market. Meeting regulatory requirements demands substantial investments in research, development and quality control.

In response to the aforementioned challenges, packaging companies have developed solutions that meet regulatory standards. For instance, Schott AG introduced the iQ platform in 2020, which provides a comprehensive approach to quality control, helping vaccine manufacturers maintain compliance throughout the packaging process.

A series of Cold Chain Challenges

One of the most significant restraints in the vaccine packaging market is the need to maintain a cold chain throughout the distribution process. Many vaccines, especially those for diseases like measles, mumps, rubella and COVID-19, require strict temperature control to remain effective. According to the World Health Organization (WHO), up to 50% of vaccines may be wasted globally each year due to temperature control issues during transportation and storage.

In response to these challenges, several innovations have emerged. In 2020, for example, Sonoco ThermoSafe introduced the Pegasus ULD, a temperature-controlled container designed for air transport. The product aims to address cold chain issues by providing a reliable solution for the safe transport of vaccines and other temperature-sensitive pharmaceuticals.

Segment Analysis

The global vaccine packaging market is segmented based on type, level, end-user and region.

Growing need to ensure safe and effective distribution of vaccines

The global vaccine packaging market plays a crucial role in ensuring the safe and effective distribution of vaccines globally. Within this market, the segment dedicated to vaccine cool bags is of paramount importance. Such products are designed to maintain the required temperature for vaccines during transportation and storage, addressing one of the most critical challenges in vaccine distribution.

The World Health Organization (WHO) estimates that over 50% of vaccines are wasted each year due to temperature deviations. The startling figure emphasizes the need for robust temperature control measures during vaccine distribution. In U.S., the Centers for Disease Control and Prevention (CDC) has reported that vaccine wastage due to temperature issues can range from 25% to 50%.

The statistics from government sources highlight the challenges faced in vaccine distribution due to temperature deviations, emphasizing the need for effective temperature control solutions. As the world continues to grapple with the importance of vaccination in public health, vaccine cool bags play a pivotal role in ensuring that vaccines reach their intended recipients in safe and effective conditions.

Geographical Penetration

Increasing Vaccine Production, Rising Healthcare Awareness and A Growing Focus On Quality and Safety In the Pharmaceutical Sector

Asia-Pacific has emerged as a key player in the global vaccine packaging market, driven by a combination of factors including increasing vaccine production, rising healthcare awareness and a growing focus on quality and safety in the pharmaceutical sector. The importance of vaccine packaging cannot be overstated. It plays a crucial role in preserving the potency and efficacy of vaccines, ensuring that they reach patients in optimal condition.

Asia-Pacific has rapidly evolved into a hub for vaccine production. With countries such as India and China at the forefront, the region manufactures a significant portion of the world's vaccines. The respective development has naturally spurred growth in the vaccine packaging sector. Moreover, government investments and initiatives aimed at bolstering the pharmaceutical sector have further fueled the vaccine packaging market's growth.

While the Asia-Pacific has made significant strides in vaccine packaging, it's not without its challenges. Ensuring the quality and safety of vaccine packaging materials, as well as meeting the increasing demand for vaccines, are ongoing concerns. However, with government support, private sector innovation and a growing awareness of the importance of vaccine packaging, the Asia-Pacific is poised for continued growth in this vital sector.

Competitive Landscape

The major global players in the market are: Gerresheimer AG, West Pharmaceutical Services, Inc, Becton, Dickinson & Company, SCHOTT AG, SGD S.A., Catalent, Inc, Stevanato Group, Nipro Corporation, Piramal Glass Private Limited and UDG Healthcare plc.

COVID-19 Impact Analysis

The COVID-19 pandemic, which began in late 2019, has had profound effects on every aspect of our lives, including the healthcare and pharmaceutical industries. One of the critical components of the global response to the pandemic has been the development and distribution of vaccines. The vaccine packaging industry plays a pivotal role in ensuring the safe and efficient delivery of vaccines globally.

The COVID-19 pandemic triggered an unprecedented global demand for vaccines. Pharmaceutical companies raced to develop vaccines to combat the virus, leading to a significant increase in vaccine production. The respective surge in vaccine production, in turn, had a direct impact on the vaccine packaging market.

According to U.S. Food and Drug Administration (FDA), as of December 2020, over 250 COVID-19 vaccine candidates were in various stages of development. The aforementioned statistics is translated to an enormous demand for vaccine packaging materials such as vials, ampoules, syringes and vial seals. Companies were forced to develop packaging solutions that could ensure the safe storage and transportation of vaccines at various temperature requirements.

Russia-Ukraine War Impact Analysis

Armed conflicts in key manufacturing regions, such as Ukraine, can disrupt global supply chains. Ukraine, for example, is known for its production of pharmaceutical and chemical products, including packaging materials. Any interruptions in the supply of materials from conflict zones can lead to shortages and increased prices for packaging materials, affecting vaccine production and distribution.

Further, global supply chain disruptions often lead to increased transportation and logistics costs. Manufacturers may need to find alternative suppliers or transportation routes, which can result in higher expenses. Such increased costs may be passed on to consumers, healthcare providers and governments purchasing vaccines.

Moroever, the eopolitical instability can also lead to regulatory challenges. Regulatory agencies in various countries may impose stricter controls or inspections on products originating from or passing through conflict zones. Such additional requirements can create delays in getting vaccines to market.

By Type

  • Vaccine Cool Bags
  • Vials and Ampoules
  • Corrugated Boxes
  • Others

By Level

  • Primary
  • Secondary
  • Tertiary

By End-User

  • Biopharmaceutical Companies
  • Hospitals
  • Medical Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In 2023, Va-Q-tec, a portable and reusable temperature-controlled packaging solution lunched COOLPACK, a vaccine cool bag designed for the safe transportation of vaccines, particularly in regions with limited infrastructure. The COOLPACK's innovative design allows it to maintain temperature for extended periods, addressing the challenges of vaccine distribution in remote areas.
  • In 2021, Sonoco ThermoSafe introduced the Pegasus ULD, a unit load device designed for the air transportation of temperature-sensitive pharmaceuticals, including vaccines. The product features advanced insulation and phase change materials, ensuring precise temperature control and protection during air travel, which is crucial for the global distribution of vaccines.
  • Softbox introduced the Tempcell ECO in 2022. The product is a single-use, fully-recyclable packaging solution, designed for the transportation of temperature-sensitive pharmaceuticals and vaccines. It offers temperature control for up to 168 hours, making it ideal for long-distance vaccine distribution.

Why Purchase the Report?

  • To visualize the global vaccine packaging market segmentation based on type, level, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of vaccine packaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global vaccine packaging market report would provide approximately 61 tables, 59 figures and 192 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Level
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns
      • 4.1.1.2. Increasing Access to Vaccines in Emerging Markets
      • 4.1.1.3. Growing Global Vaccination Efforts
    • 4.1.2. Restraints
      • 4.1.2.1. Growing Need for Regulatory Compliance
      • 4.1.2.2. A series of Cold Chain Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Vaccine Cool Bags*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Vials and Ampoules
  • 7.4. Corrugated Boxes
  • 7.5. Others

8. By Level

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 8.1.2. Market Attractiveness Index, By Level
  • 8.2. Primary*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Secondary
  • 8.4. Tertiary

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Biopharmaceutical Companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals
  • 9.4. Medical Laboratories
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Gerresheimer AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. West Pharmaceutical Services, Inc
  • 12.3. Becton, Dickinson & Company
  • 12.4. SCHOTT AG
  • 12.5. SGD S.A.
  • 12.6. Catalent, Inc
  • 12.7. Stevanato Group
  • 12.8. Nipro Corporation
  • 12.9. Piramal Glass Private Limited
  • 12.10. UDG Healthcare plc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us